Loading...

INO NS 0.9% – SODIUM CHLORIDE

Inochi Sodium Chloride 0.9%

100 ml

COMPOSITION

Sodium Chloride 0.90 g
Water for Injection Ad 100 mL

250 ml

COMPOSITION

Sodium Chloride 2.25 g
Water for Injection Ad 250 mL

500 ml

COMPOSITION

Sodium Chloride 4.50 g
Water for Injection Ad 500 mL

DESCRIPTION 
A sterile, colorless and non-pyrogenic solution for intravenous administration.

DRUG MECHANISM 

  • Intravenous normal saline or sodium chloride (9.00 g / L) provides a source of sodium ions (154 mmol / L) and chloride ions (154 mmol / L) with 308 mOsm / L osmotic pressure. Normal saline is indicated for fluid resuscitation for patients with dehydration or shock. 1L of intravenous Normal Saline adds approximately 200 mL intravascular volume and 800 mL enters the interstitial fluid.
  • Sodium ions are the major cation in the extracellular fluid (ECF) and as such are the major contributor to the blood plasma osmotic pressure. Chloride ions are the major anion in the ECF. In the case of dehydration, where it is almost invariably associated with some loss of salt (sodium chloride), treatment using intravenous administration of a normal saline solution is necessary to replace water lost from the body, as well as to restore salt concentrations to normal levels within body fluids.

INDICATION 

  • Parenteral replacement of fluid, sodium and chloride ions.
  • Diluent for administering parenteral medicine.

DOSAGE AND ADMINISTRATION 
Always use according to physician’s instructions. Dosage or injection should be used in accordance with the condition of each patient.

CONTRAINDICATIONS 
Not to be used as an emetic.

CAUTION 

  • This solution should be used with care in patients with oedema peripheral pulmonary,congestive heart failure, impaired renal function and preeclampsia.
  • For comfort during administration, ensure that dosage form for the delivery is iso-osmotic with body fluids.
  • Excessive administration or administration at a flow rate that is too high causes oedema, particularly in patients with cardiovascular disease or impaired renal function. In general, this should not lead to significant abnormality due to iso-osmotic nature of the solution.

SIDE EFFECTS 
Hypernatremia, excessive adminitration can also cause hypocalcemia.

ATTENTION 
Do not use if the bottle is damaged, has cloudy solution or contains particles.

STORAGE CONDITION 
The product has to be stored below 30°C.

PACKAGING 
Transparent polypropylene plastic bottle 100 mL
(REG NO. GKL1742600149A2)

Transparent polypropylene plastic bottle 250 mL
(REG NO. GKL1742600149A2)

Transparent polypropylene plastic bottle 500 mL
(REG NO. GKL1742600149A1)

PRESCRIPTION ONLY

PRODUCED BY

PT SATORIA ANEKA INDUSTRI
Jalan Raya Sambisirah, Wonorejo, Pasuruan – Jawa Timur


Download brochure for Satoria Pharma's Products

Satoria Pharma, registered under a legal name PT. Satoria Aneka Industri, is an Indonesian based pharmaceutical manufacturing company that is established in early 2014. Read more

INFORMATION

SATORIA TOWER
Jl. Pradah Jaya I No.1, Pradahkalikendal, Kec. Dukuhpakis, Surabaya, Jawa Timur 60226

Email : info@satoriapharma.com

Telepon : +62 31 9900 0970

Fax : +62 31 9900 0971